Research Article
Study of Pharmacodynamic and Pharmacokinetic Interaction of Bojungikki-Tang with Aspirin in Healthy Subjects and Ischemic Stroke Patients
Table 1
Baseline characteristics of healthy subjects and ischemic stroke patients.
| | | Healthy subjects () | Ischemic stroke | | Aspirin + placebo () | Aspirin + BJIKT () | P |
| | Age | | | | NS | | Male (n, %) | 10 (100) | 13 (61.9) | 14 (63.6) | NS | | BMI (kg/m2) | | | | NS | | Heart disease (n, %) | 0 | 3 (14.2) | 7 (31.8) | NS | | HBP (n, %) | 0 | 13 (61.9) | 14 (63.6) | NS | | Diabetes (n, %) | 0 | 6 (28.5) | 6 (27.2) | NS | | Dyslipidemia (n, %) | 0 | 10 (47.6) | 9 (40.9) | NS | | Smoking (n, %) | 0 | 2 (9.5) | 2 (9.1) | NS | | Alcohol (n, %) | 0 | 7 (33.3) | 8 (36.3) | NS |
|
|
BJIKT: Bojungikki-tang, BMI: body mass index, and HBP: high blood pressure.
|
